Skip to main content
Erschienen in: Cancer Causes & Control 8/2008

01.10.2008 | Review Article

Systematic review of prostate cancer’s association with body size in childhood and young adulthood

verfasst von: Whitney R. Robinson, Charles Poole, Paul A. Godley

Erschienen in: Cancer Causes & Control | Ausgabe 8/2008

Einloggen, um Zugang zu erhalten

Abstract

Body size relatively early in life may influence men’s later rate of prostate cancer. We searched for published, English-language studies of the association between prostate cancer incidence or mortality and body size between ages 5 and 29 years. We summarized analyses of childhood body size, early-adult waist circumference, and early-adult body mass index (BMI). Most study designs were case–control or retrospective cohort studies, in which body size was self-reported and recalled. The few studies of childhood body size and early-adult waist circumference indicated null or weak associations. The results from studies of early-adult BMI were heterogeneous (p = 0.04) and showed evidence of funnel plot asymmetry. The random-effects rate ratio (RR) was 1.06 (95% confidence interval [CI]: 0.99, 1.14) per five-unit increase in BMI. Studies using measured (as opposed to self-recalled) height and weight (n = 3) tended to produce stronger associations: fixed-effects summary RR = 1.22 (1.06, 1.39). The same was true for studies that did not adjust for later-life BMI (n = 13): fixed-effects RR = 1.13 (1.06, 1.21). Examining only analyses of advanced or high-grade prostate cancers, results were heterogeneous (p < 0.01). The random-effects summary RR per five units of BMI was 1.01 (95% CI: 0.89, 1.15). In all the reviewed studies, the vast majority of men were of normal weight in childhood and early adulthood. Few studies presented data describing the association between prostate cancer and obesity (e.g., early-adult BMI ≥ 30). The exact relationships between early-life body size and prostate cancer remain unclear but appear to be weak.
Literatur
1.
Zurück zum Zitat Freedland SJ, Platz EA (2007) Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev 29:88–97PubMedCrossRef Freedland SJ, Platz EA (2007) Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev 29:88–97PubMedCrossRef
2.
Zurück zum Zitat MacInnis RJ, English DR (2006) Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 17(8):989–1003PubMedCrossRef MacInnis RJ, English DR (2006) Body size and composition and prostate cancer risk: systematic review and meta-regression analysis. Cancer Causes Control 17(8):989–1003PubMedCrossRef
3.
Zurück zum Zitat Whittemore AS, Paffenbarger RS Jr, Anderson K, Lee JE (1984) Early precursors of urogenital cancers in former college men. J Urol 132(6):1256–1261PubMed Whittemore AS, Paffenbarger RS Jr, Anderson K, Lee JE (1984) Early precursors of urogenital cancers in former college men. J Urol 132(6):1256–1261PubMed
4.
Zurück zum Zitat Whittemore AS, Paffenbarger RS Jr, Anderson K, Lee JE (1985) Early precursors of site-specific cancers in college men and women. J Natl Cancer Inst 74(1):43–51PubMed Whittemore AS, Paffenbarger RS Jr, Anderson K, Lee JE (1985) Early precursors of site-specific cancers in college men and women. J Natl Cancer Inst 74(1):43–51PubMed
5.
Zurück zum Zitat Ilic M, Vlajinac H, Marinkovic J (1996) Case–control study of risk factors for prostate cancer. Br J Cancer 74(10):1682–1686PubMed Ilic M, Vlajinac H, Marinkovic J (1996) Case–control study of risk factors for prostate cancer. Br J Cancer 74(10):1682–1686PubMed
6.
Zurück zum Zitat Dal Maso L, Zucchetto A, La Vecchia C, Montella M, Conti E, Canzonieri V et al (2004) Prostate cancer and body size at different ages: an Italian multicentre case–control study. Brit J Cancer 90(11):2176–2180PubMed Dal Maso L, Zucchetto A, La Vecchia C, Montella M, Conti E, Canzonieri V et al (2004) Prostate cancer and body size at different ages: an Italian multicentre case–control study. Brit J Cancer 90(11):2176–2180PubMed
7.
Zurück zum Zitat Friedenreich CM, McGregor SE, Courneya KS, Angyalfi SJ, Elliott FG (2004) Case–control study of anthropometric measures and prostate cancer risk. Int J Cancer 110(2):278–283PubMedCrossRef Friedenreich CM, McGregor SE, Courneya KS, Angyalfi SJ, Elliott FG (2004) Case–control study of anthropometric measures and prostate cancer risk. Int J Cancer 110(2):278–283PubMedCrossRef
8.
Zurück zum Zitat Greenwald P, Damon A, Kirmss V, Polan AK (1974) Physical and demographic features of men before developing cancer of the prostate. J Natl Cancer Inst 53(2):341–346PubMed Greenwald P, Damon A, Kirmss V, Polan AK (1974) Physical and demographic features of men before developing cancer of the prostate. J Natl Cancer Inst 53(2):341–346PubMed
9.
Zurück zum Zitat Nomura A, Heilbrun LK, Stemmermann GN (1985) Body mass index as a predictor of cancer in men. J Natl Cancer Inst 74(2):319–323PubMed Nomura A, Heilbrun LK, Stemmermann GN (1985) Body mass index as a predictor of cancer in men. J Natl Cancer Inst 74(2):319–323PubMed
10.
Zurück zum Zitat Andersson SO, Baron J, Wolk A, Lindgren C, Bergstrom R, Adami HO (1995) Early life risk factors for prostate cancer: a population-based case–control study in Sweden. Cancer Epidemiol Biomarkers Prev 4(3):187–192PubMed Andersson SO, Baron J, Wolk A, Lindgren C, Bergstrom R, Adami HO (1995) Early life risk factors for prostate cancer: a population-based case–control study in Sweden. Cancer Epidemiol Biomarkers Prev 4(3):187–192PubMed
11.
Zurück zum Zitat Cerhan JR, Torner JC, Lynch CF, Rubenstein LM, Lemke JH, Cohen MB et al (1997) Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States). Cancer Causes Control 8(2):229–238PubMedCrossRef Cerhan JR, Torner JC, Lynch CF, Rubenstein LM, Lemke JH, Cohen MB et al (1997) Association of smoking, body mass, and physical activity with risk of prostate cancer in the Iowa 65+ Rural Health Study (United States). Cancer Causes Control 8(2):229–238PubMedCrossRef
12.
Zurück zum Zitat Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC (1997) Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 6(8):557–563PubMed Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Willett WC (1997) Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 6(8):557–563PubMed
13.
Zurück zum Zitat Key TJ, Silcocks PB, Davey GK, Appleby PN, Bishop DT (1997) A case–control study of diet and prostate cancer. Br J Cancer 76(5):678–687PubMed Key TJ, Silcocks PB, Davey GK, Appleby PN, Bishop DT (1997) A case–control study of diet and prostate cancer. Br J Cancer 76(5):678–687PubMed
14.
Zurück zum Zitat Hsing AW, Deng J, Sesterhenn IA, Mostofi FK, Stanczyk FZ, Benichou J et al (2000) Body size and prostate cancer: a population-based case–control study in China. Cancer Epidemiol Biomarkers Prev 9(12):1335–1341PubMed Hsing AW, Deng J, Sesterhenn IA, Mostofi FK, Stanczyk FZ, Benichou J et al (2000) Body size and prostate cancer: a population-based case–control study in China. Cancer Epidemiol Biomarkers Prev 9(12):1335–1341PubMed
15.
Zurück zum Zitat Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA (2000) Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol 151(6):541–549PubMed Schuurman AG, Goldbohm RA, Dorant E, van den Brandt PA (2000) Anthropometry in relation to prostate cancer risk in the Netherlands Cohort Study. Am J Epidemiol 151(6):541–549PubMed
16.
Zurück zum Zitat Lee IM, Sesso HD, Paffenbarger RS Jr (2001) A prospective cohort study of physical activity and body size in relation to prostate cancer risk (United States). Cancer Causes Control 12(2):187–193PubMedCrossRef Lee IM, Sesso HD, Paffenbarger RS Jr (2001) A prospective cohort study of physical activity and body size in relation to prostate cancer risk (United States). Cancer Causes Control 12(2):187–193PubMedCrossRef
17.
Zurück zum Zitat Okasha M, McCarron P, McEwen J, Smith GD (2002) Body mass index in young adulthood and cancer mortality: a retrospective cohort study. J Epidemiol Community Health 56(10):780–784PubMedCrossRef Okasha M, McCarron P, McEwen J, Smith GD (2002) Body mass index in young adulthood and cancer mortality: a retrospective cohort study. J Epidemiol Community Health 56(10):780–784PubMedCrossRef
18.
Zurück zum Zitat Engeland A, Tretli S, Bjorge T (2003) Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men. Br J Cancer 89(7):1237–1242PubMedCrossRef Engeland A, Tretli S, Bjorge T (2003) Height, body mass index, and prostate cancer: a follow-up of 950000 Norwegian men. Br J Cancer 89(7):1237–1242PubMedCrossRef
19.
Zurück zum Zitat Giles GG, Severi G, English DR, McCredie MR, MacInnis R, Boyle P et al (2003) Early growth, adult body size and prostate cancer risk. Int J Cancer 103(2):241–245PubMedCrossRef Giles GG, Severi G, English DR, McCredie MR, MacInnis R, Boyle P et al (2003) Early growth, adult body size and prostate cancer risk. Int J Cancer 103(2):241–245PubMedCrossRef
20.
Zurück zum Zitat Jonsson F, Wolk A, Pedersen NL, Lichtenstein P, Terry P, Ahlbom A et al (2003) Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. Int J Cancer 106(4):594–599PubMedCrossRef Jonsson F, Wolk A, Pedersen NL, Lichtenstein P, Terry P, Ahlbom A et al (2003) Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. Int J Cancer 106(4):594–599PubMedCrossRef
21.
Zurück zum Zitat Robinson WR, Stevens J, Gammon MD, John EM (2005) Obesity before age 30 years and risk of advanced prostate cancer. Am J Epidemiol 161(12):1107–1114PubMedCrossRef Robinson WR, Stevens J, Gammon MD, John EM (2005) Obesity before age 30 years and risk of advanced prostate cancer. Am J Epidemiol 161(12):1107–1114PubMedCrossRef
22.
Zurück zum Zitat Wright ME, Chang SC, Schatzkin A, Albanes D, Kipnis V, Mouw T et al (2007) Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 109(4):675–684PubMedCrossRef Wright ME, Chang SC, Schatzkin A, Albanes D, Kipnis V, Mouw T et al (2007) Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 109(4):675–684PubMedCrossRef
23.
Zurück zum Zitat Liu X, Rybicki BA, Casey G, Witte JS (2005) Relationship between body size and prostate cancer in a sibling based case–control study. J Urol 174(6):2169–2173PubMedCrossRef Liu X, Rybicki BA, Casey G, Witte JS (2005) Relationship between body size and prostate cancer in a sibling based case–control study. J Urol 174(6):2169–2173PubMedCrossRef
24.
Zurück zum Zitat Littman AJ, White E, Kristal AR (2007) Anthropometrics and prostate cancer risk. Am J Epidemiol 165(11):1271–1279PubMedCrossRef Littman AJ, White E, Kristal AR (2007) Anthropometrics and prostate cancer risk. Am J Epidemiol 165(11):1271–1279PubMedCrossRef
25.
Zurück zum Zitat Cox B, Sneyd MJ, Paul C, Skegg DCG (2006) Risk factors for prostate cancer: A national case–control study. Int J Cancer 119(7):1690–1694PubMedCrossRef Cox B, Sneyd MJ, Paul C, Skegg DCG (2006) Risk factors for prostate cancer: A national case–control study. Int J Cancer 119(7):1690–1694PubMedCrossRef
26.
Zurück zum Zitat Greene F, Page D, Fleming I, Fritz A, Balch C, Haller D et al (2002) AJCC cancer staging manual, 6th edn. Springer Greene F, Page D, Fleming I, Fritz A, Balch C, Haller D et al (2002) AJCC cancer staging manual, 6th edn. Springer
27.
Zurück zum Zitat Gleason D (1977) Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M (ed) Urologic pathology: the prostate. Lea and Febiger, Philadelphia, pp 171–198 Gleason D (1977) Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M (ed) Urologic pathology: the prostate. Lea and Febiger, Philadelphia, pp 171–198
28.
Zurück zum Zitat Weinberg CR (1993) Toward a clearer definition of confounding. Am J Epidemiol 137(1):1–8PubMed Weinberg CR (1993) Toward a clearer definition of confounding. Am J Epidemiol 137(1):1–8PubMed
29.
Zurück zum Zitat Rothman KJ, Greenland S (1998) Modern epidemiology, 2nd edn. Lippincott-Raven, Philadelphia, 125 pp Rothman KJ, Greenland S (1998) Modern epidemiology, 2nd edn. Lippincott-Raven, Philadelphia, 125 pp
30.
Zurück zum Zitat Kleinbaum DG, Kupper LL, Morgenstern H (1982) Epidemiologic research: principles, quantitative methods. Lifetime Learning Publications, Belmont, CA, 257 pp Kleinbaum DG, Kupper LL, Morgenstern H (1982) Epidemiologic research: principles, quantitative methods. Lifetime Learning Publications, Belmont, CA, 257 pp
31.
Zurück zum Zitat Greenland S, Pearl J, Robins JM (1999) Causal diagrams for epidemiologic research. Epidemiology 10(1):37–48PubMedCrossRef Greenland S, Pearl J, Robins JM (1999) Causal diagrams for epidemiologic research. Epidemiology 10(1):37–48PubMedCrossRef
32.
Zurück zum Zitat Breslow NE, Day NE (1980) Statistical methods in cancer research, vol I - the analysis of case–control studies. IARC Sci Publ. (32), 107 pp Breslow NE, Day NE (1980) Statistical methods in cancer research, vol I - the analysis of case–control studies. IARC Sci Publ. (32), 107 pp
33.
Zurück zum Zitat Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135(11):1301–1309PubMed Greenland S, Longnecker MP (1992) Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 135(11):1301–1309PubMed
34.
Zurück zum Zitat Orsini N, Bellocco R, Greenland S (2006) Generalized least squares for trend estimation of summarized dose-response data. Stata J 6(1):40–57 Orsini N, Bellocco R, Greenland S (2006) Generalized least squares for trend estimation of summarized dose-response data. Stata J 6(1):40–57
35.
Zurück zum Zitat Sterne JA, Gavaghan D, Egger M (2000) Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 53(11):1119–1129PubMedCrossRef Sterne JA, Gavaghan D, Egger M (2000) Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 53(11):1119–1129PubMedCrossRef
36.
Zurück zum Zitat Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101PubMedCrossRef Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088–1101PubMedCrossRef
37.
Zurück zum Zitat Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research Ed) 315(7109):629–634 Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research Ed) 315(7109):629–634
38.
Zurück zum Zitat Duval S, Tweedie R (2000) A nonparametric “trim and fill” method of accounting for publication bias in meta-analysis. J Am Stat Assoc 95(449):89–98CrossRef Duval S, Tweedie R (2000) A nonparametric “trim and fill” method of accounting for publication bias in meta-analysis. J Am Stat Assoc 95(449):89–98CrossRef
39.
Zurück zum Zitat Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56(2):455–463PubMedCrossRef Duval S, Tweedie R (2000) Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56(2):455–463PubMedCrossRef
40.
Zurück zum Zitat Thompson SG, Higgins JP (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21(11):1559–1573PubMedCrossRef Thompson SG, Higgins JP (2002) How should meta-regression analyses be undertaken and interpreted? Stat Med 21(11):1559–1573PubMedCrossRef
41.
Zurück zum Zitat Thompson SG, Sharp SJ (1999) Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 18(20):2693–2708PubMedCrossRef Thompson SG, Sharp SJ (1999) Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 18(20):2693–2708PubMedCrossRef
42.
Zurück zum Zitat Sharp SJ (1998) Meta-analysis regression. Stata Tech Bull 42:16–22 Sharp SJ (1998) Meta-analysis regression. Stata Tech Bull 42:16–22
43.
Zurück zum Zitat Wright ME, Chang SC, Schatzkin A, Albanes D, Kipnis V, Mouw T et al (2007) Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 109(4):675–684PubMedCrossRef Wright ME, Chang SC, Schatzkin A, Albanes D, Kipnis V, Mouw T et al (2007) Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer 109(4):675–684PubMedCrossRef
44.
45.
Zurück zum Zitat Troiano RP, Flegal KM (1998) Overweight children and adolescents: description, epidemiology, and demographics. Pediatrics 101(3 Pt 2):497–504PubMed Troiano RP, Flegal KM (1998) Overweight children and adolescents: description, epidemiology, and demographics. Pediatrics 101(3 Pt 2):497–504PubMed
46.
Zurück zum Zitat Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL (1998) Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord 22(1):39–47PubMedCrossRef Flegal KM, Carroll MD, Kuczmarski RJ, Johnson CL (1998) Overweight and obesity in the United States: prevalence and trends, 1960–1994. Int J Obes Relat Metab Disord 22(1):39–47PubMedCrossRef
47.
Zurück zum Zitat Troiano RP, Flegal KM, Kuczmarski RJ, Campbell SM, Johnson CL (1995) Overweight prevalence and trends for children and adolescents. The National Health and Nutrition Examination Surveys, 1963 to 1991. Arch Pediatr Adolesc Med 149(10):1085–1091PubMed Troiano RP, Flegal KM, Kuczmarski RJ, Campbell SM, Johnson CL (1995) Overweight prevalence and trends for children and adolescents. The National Health and Nutrition Examination Surveys, 1963 to 1991. Arch Pediatr Adolesc Med 149(10):1085–1091PubMed
48.
Zurück zum Zitat Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW et al (2006) Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 15(10):1977–1983PubMedCrossRef Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW et al (2006) Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial. Cancer Epidemiol Biomarkers Prev 15(10):1977–1983PubMedCrossRef
49.
Zurück zum Zitat Stevens J, Keil JE, Waid LR, Gazes PC (1990) Accuracy of current, 4-year, and 28-year self-reported body weight in an elderly population. Am J Epidemiol 132(6):1156–1163PubMed Stevens J, Keil JE, Waid LR, Gazes PC (1990) Accuracy of current, 4-year, and 28-year self-reported body weight in an elderly population. Am J Epidemiol 132(6):1156–1163PubMed
50.
Zurück zum Zitat Juni P, Witschi A, Bloch R, Egger M (1999) The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282(11):1054–1060PubMedCrossRef Juni P, Witschi A, Bloch R, Egger M (1999) The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 282(11):1054–1060PubMedCrossRef
51.
Zurück zum Zitat Greenland S, O’Rourke K (2001) On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions. Biostatistics 2(4):463–471PubMedCrossRef Greenland S, O’Rourke K (2001) On the bias produced by quality scores in meta-analysis, and a hierarchical view of proposed solutions. Biostatistics 2(4):463–471PubMedCrossRef
52.
Zurück zum Zitat Freedland SJ, Giovannucci E, Platz EA (2006) Are findings from studies of obesity and prostate cancer really in conflict? Cancer Causes Control 17(1):5–9PubMedCrossRef Freedland SJ, Giovannucci E, Platz EA (2006) Are findings from studies of obesity and prostate cancer really in conflict? Cancer Causes Control 17(1):5–9PubMedCrossRef
53.
Zurück zum Zitat Rodriguez C, Freedland SJ, Deka A, Jacobs EJ, McCullough ML, Patel AV et al (2007) Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 16(1):63–69PubMedCrossRef Rodriguez C, Freedland SJ, Deka A, Jacobs EJ, McCullough ML, Patel AV et al (2007) Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 16(1):63–69PubMedCrossRef
Metadaten
Titel
Systematic review of prostate cancer’s association with body size in childhood and young adulthood
verfasst von
Whitney R. Robinson
Charles Poole
Paul A. Godley
Publikationsdatum
01.10.2008
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 8/2008
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-008-9142-9

Weitere Artikel der Ausgabe 8/2008

Cancer Causes & Control 8/2008 Zur Ausgabe

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Das sind die führenden Symptome junger Darmkrebspatienten

Darmkrebserkrankungen in jüngeren Jahren sind ein zunehmendes Problem, das häufig längere Zeit übersehen wird, gerade weil die Patienten noch nicht alt sind. Welche Anzeichen Ärzte stutzig machen sollten, hat eine Metaanalyse herausgearbeitet.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.